News

David Uffer is a 30+ year seasoned executive having a career dedicated to the Medtech industry. He currently serves as the VP Medtech at General Inception where he leads investments and the portfolio in early stage Medtech companies. In his career he has screened over 15,000 companies and continues to engage over 600 annually.

Prior to General Inception David was the Senior Partner and VP of Medtech at Alira Health, a global advisory firm.  He advised companies in all aspects of commercialization from Regulatory, Clinical Affairs, HEOR, go to market strategies and transaction advisory.

In previous roles David led Business Development for a $5B division of Medtronic (legacy Covidien) in their respiratory, monitoring and med/surg products business including renal care, general surgery, nutrition and wound care. He led deals in M&A, distribution, co-development and also executed minority equity investments in early stage companies of strategic interest. Prior to Medtronic, David was Director of Corporate Development at Hologic running strategy and deal flow while leading deals across gyn surgery, breast health, and molecular diagnostics.

David also has managed Boston Scientific’s strategy and business development function in vascular surgery, interventional medicine and oncology. He has held management roles at Integra Lifesciences leading neuromonitoring and neurosurgery business units. David initiated his career with Abbott Labs in their Diagnostics Division, managing US and APAC market development and global market assessments.